Tag: Harvard Bioscience

HOLLISTON, Mass., July 18, 2019 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that Michael Rossi has been named Chief Financial Officer, effective immediately.  Rossi most recently served as Chief Financial Officer of Laborie Medical Technologies, a global medical devices company. Jim Green, Chairman, President and CEO stated, “Mike Rossi’s deep experience in finance, public company accounting, global business operations,... Read more

Jul 08,2019 HOLLISTON, Mass., July 08, 2019 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that James Green has been named President and Chief Executive Officer of the Company by its Board of Directors, effective immediately. Additionally, Harvard Bioscience’s Board has appointed Bertrand Loy as Lead Independent Director.  Green has been a member of the Company’s Board since April 2015, and Chairman of... Read more

Oct 22,2018 Seasoned Financial Executive With More Than a Decade in Global Life Science Instrumentation, Will Begin on November 26 HOLLISTON, Mass., Oct. 22, 2018 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, appointed Kam Unninayar as Chief Financial Officer (CFO), effective November 26, 2018. Ms. Unninayar... Read more

Aug 22,2018 CFO Resigns to Pursue New Opportunity HOLLISTON, Mass., Aug. 22, 2018 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, today announced the resignation of Robert E. Gagnon, Chief Financial Officer, effective August 31, 2018. The Company has initiated a search for... Read more

HOLLISTON, Mass., Oct. 25, 2017 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, appointed Katherine Eade and Thomas Loewald as Class II directors of the Board of Directors, effective as of October 24, 2017. Ms. Eade is Director,... Read more

HOLLISTON, Mass., June 07, 2017 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, has elected James Green, a current Board member, as the new Chairman of its Board of Directors effective June 5, 2017.  Earl R. Lewis has served... Read more